Blood Neutrophil-to-Lymphocyte Ratio Predicts Tumor Recurrence in Patients with Hepatocellular Carcinoma Within Milan Criteria After Hepatectomy

Overview

Journal Yonsei Med J

Specialty General Medicine

Date 2016 Jul 13

PMID 27401641

Citations 12

Authors

Xu Guang Hu

Wei Mao

Yong Keun Park

Wei Guang Xu

Bong Wan Kim

Hee Jung Wang

Affiliations

Soon will be listed here.

Abstract

Purpose: The systemic inflammation biomarker, Neutrophil-to-Lymphocyte Ratio (NLR), has been reported as one of the adverse prognostic factors for hepatocellular carcinoma (HCC) patient. The purpose of this study was to evaluate whether NLR could predict the risk of recurrence and death for the HCC patient, according to Milan criteria after hepatectomy.

Materials And Methods: Retrospective analysis was performed on a database of HCC patients who underwent hepatectomy between March 2001 and December 2011. The cutoff value of NLR was decided by receiver operating characteristic (ROC) curve analysis. Univariate and multivariate regression analyses were performed to identify predictive factors of recurrence and death.

Results: A total of 213 patients were included in the present study. The median follow-up period was 48 months. One hundred and seven patients were experienced tumor recurrence; forty of them recurred within 12 months (early recurrence). NLR ≥1.505, albumin ≤3.75 g/dL, microvascular invasion and high grade of cirrhosis were found to be independent factors for adverse recurrence-free survival in multivariate regression analysis. And NLR ≥1.945 was also found as a prognosis factor for early recurrence by univariate regression analysis.

Conclusion: Elevated preoperative NLR can be easily obtained and reliable biomarker for assessing the tumor recurrence and early recurrence of Milan criteria HCC after the initial hepatectomy.

Citing Articles

Emerging Prognostic Markers in Patients Undergoing Liver Resection for Hepatocellular Carcinoma: A Narrative Review.

Panettieri E, Campisi A, De Rose A, Mele C, Giuliante F, Vauthey J Cancers (Basel). 2024; 16(12).

PMID: 38927889 PMC: 11201456. DOI: 10.3390/cancers16122183.

Significant association between high neutrophil-lymphocyte ratio and poor prognosis in patients with hepatocellular carcinoma: a systematic review and meta-analysis.

Xu C, Wu F, Du L, Dong Y, Lin S Front Immunol. 2023; 14:1211399.

PMID: 37809083 PMC: 10551132. DOI: 10.3389/fimmu.2023.1211399.

Therapeutic effect of postoperative adjuvant transcatheter arterial chemoembolization based on the neutrophil-to-lymphocyte ratio.

Feng G, Shi Z, Zhao Y, Chen K, Tao J, Wei X Front Surg. 2023; 9:1072451.

PMID: 36684128 PMC: 9852644. DOI: 10.3389/fsurg.2022.1072451.

Development of nomogram models of inflammatory markers based on clinical database to predict prognosis for hepatocellular carcinoma after surgical resection.

Mao S, Yu X, Sun J, Yang Y, Shan Y, Sun J BMC Cancer. 2022; 22(1):249.

PMID: 35255845 PMC: 8900373. DOI: 10.1186/s12885-022-09345-2.

Neutrophil-to-lymphocyte ratio predicts prognosis of patients with hepatocellular carcinoma: a systematic review and meta-analysis.

Lin S, Hu S, Ran Y, Wu F Transl Cancer Res. 2022; 10(4):1667-1678.

PMID: 35116492 PMC: 8799187. DOI: 10.21037/tcr-20-3237.

References

Poon R, Fan S, Wong J . Does diabetes mellitus influence the perioperative outcome or long term prognosis after resection of hepatocellular carcinoma?. Am J Gastroenterol. 2002; 97(6):1480-8. DOI: 10.1111/j.1572-0241.2002.05792.x. View

Harimoto N, Shirabe K, Nakagawara H, Toshima T, Yamashita Y, Ikegami T . Prognostic factors affecting survival at recurrence of hepatocellular carcinoma after living-donor liver transplantation: with special reference to neutrophil/lymphocyte ratio. Transplantation. 2013; 96(11):1008-12. DOI: 10.1097/TP.0b013e3182a53f2b. View

EDMONDSON H, STEINER P . Primary carcinoma of the liver: a study of 100 cases among 48,900 necropsies. Cancer. 1954; 7(3):462-503. DOI: 10.1002/1097-0142(195405)7:3<462::aid-cncr2820070308>3.0.co;2-e. View

Kuang D, Peng C, Zhao Q, Wu Y, Zhu L, Wang J . Tumor-activated monocytes promote expansion of IL-17-producing CD8+ T cells in hepatocellular carcinoma patients. J Immunol. 2010; 185(3):1544-9. DOI: 10.4049/jimmunol.0904094. View

Peng S, Deng H, Yang J, Xie P, Li C, Li H . Significance and relationship between infiltrating inflammatory cell and tumor angiogenesis in hepatocellular carcinoma tissues. World J Gastroenterol. 2006; 11(41):6521-4. PMC: 4355797. DOI: 10.3748/wjg.v11.i41.6521. View

Halazun K, Hardy M, Rana A, Woodland 4th D, Luyten E, Mahadev S . Negative impact of neutrophil-lymphocyte ratio on outcome after liver transplantation for hepatocellular carcinoma. Ann Surg. 2009; 250(1):141-51. DOI: 10.1097/SLA.0b013e3181a77e59. View

Gomez D, Farid S, Malik H, Young A, Toogood G, Lodge J . Preoperative neutrophil-to-lymphocyte ratio as a prognostic predictor after curative resection for hepatocellular carcinoma. World J Surg. 2008; 32(8):1757-62. DOI: 10.1007/s00268-008-9552-6. View

Grivennikov S, Greten F, Karin M . Immunity, inflammation, and cancer. Cell. 2010; 140(6):883-99. PMC: 2866629. DOI: 10.1016/j.cell.2010.01.025. View

Cruz N, Sousa L, Sousa M, Pietrani N, Fernandes A, Gomes K . The linkage between inflammation and Type 2 diabetes mellitus. Diabetes Res Clin Pract. 2012; 99(2):85-92. DOI: 10.1016/j.diabres.2012.09.003. View

10.

Liao W, Zhang J, Zhu Q, Qin L, Yao W, Lei B . Preoperative Neutrophil-to-Lymphocyte Ratio as a New Prognostic Marker in Hepatocellular Carcinoma after Curative Resection. Transl Oncol. 2014; 7(2):248-55. PMC: 4101343. DOI: 10.1016/j.tranon.2014.02.011. View

11.

Wang Y, Huang S, Zhong J, Ke Y, Guo Z, Liu J . Impact of diabetes mellitus on the prognosis of patients with hepatocellular carcinoma after curative hepatectomy. PLoS One. 2014; 9(12):e113858. PMC: 4250061. DOI: 10.1371/journal.pone.0113858. View

12.

Sumie S, Kuromatsu R, Okuda K, Ando E, Takata A, Fukushima N . Microvascular invasion in patients with hepatocellular carcinoma and its predictable clinicopathological factors. Ann Surg Oncol. 2008; 15(5):1375-82. DOI: 10.1245/s10434-008-9846-9. View

13.

Zahorec R . Ratio of neutrophil to lymphocyte counts--rapid and simple parameter of systemic inflammation and stress in critically ill. Bratisl Lek Listy. 2001; 102(1):5-14. View

14.

Mano Y, Shirabe K, Yamashita Y, Harimoto N, Tsujita E, Takeishi K . Preoperative neutrophil-to-lymphocyte ratio is a predictor of survival after hepatectomy for hepatocellular carcinoma: a retrospective analysis. Ann Surg. 2013; 258(2):301-5. DOI: 10.1097/SLA.0b013e318297ad6b. View

15.

Maniecki M, Etzerodt A, Ulhoi B, Steiniche T, Borre M, Dyrskjot L . Tumor-promoting macrophages induce the expression of the macrophage-specific receptor CD163 in malignant cells. Int J Cancer. 2012; 131(10):2320-31. DOI: 10.1002/ijc.27506. View

16.

Kuang D, Peng C, Zhao Q, Wu Y, Chen M, Zheng L . Activated monocytes in peritumoral stroma of hepatocellular carcinoma promote expansion of memory T helper 17 cells. Hepatology. 2009; 51(1):154-64. DOI: 10.1002/hep.23291. View

17.

Huang Z, Luo J, Chen M, Li J, Shi M . Blood neutrophil-to-lymphocyte ratio predicts survival in patients with unresectable hepatocellular carcinoma undergoing transarterial chemoembolization. J Vasc Interv Radiol. 2011; 22(5):702-9. DOI: 10.1016/j.jvir.2010.12.041. View

18.

Song I, Kim K . Current status of liver diseases in Korea: hepatocellular carcinoma. Korean J Hepatol. 2009; 15 Suppl 6:S50-9. DOI: 10.3350/kjhep.2009.15.S6.S50. View

19.

Yamamoto J, Kosuge T, Takayama T, Shimada K, Yamasaki S, Ozaki H . Recurrence of hepatocellular carcinoma after surgery. Br J Surg. 1996; 83(9):1219-22. View

20.

Hotchkiss K, Ashton A, Klein R, Lenzi M, Zhu G, Schwartz E . Mechanisms by which tumor cells and monocytes expressing the angiogenic factor thymidine phosphorylase mediate human endothelial cell migration. Cancer Res. 2003; 63(2):527-33. View